ACE2 and neoplasm: Secondly, in the context of cancer progression, a protective function was described for ACE2, again counterbalancing the actions of Ang II, by inhibiting metastasis and tumor growth, in part by inactivating MAPK signaling and epithelial–mesenchymal transition (Ni et al, 2012; Qian et al, 2013).